Segment Reporting

3 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Reporting

19. Segment Reporting

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

The Company manages and aggregates its operational and financial information in accordance with two reportable segments: Rx and Consumer Health. The Rx segment consists of the Company’s prescription products. The Consumer Health segment contains the Company’s consumer healthcare products.

Select financial information for these segments is as follows:

	Three Months Ended
	September 30,
	2022		2021
	(In thousands)
Consolidated revenue:
Rx Segment	$	18,652	$	13,883
Consumer Health Segment		9,003		8,014
Consolidated revenue	$	27,655	$	21,897
Consolidated net loss:
Rx Segment	$	(2,054)	$	(26,457)
Consumer Health Segment		(827)		(1,394)
Consolidated net loss	$	(2,881)	$	(27,851)

	September 30,		June 30,
	2022		2022
	(In thousands)
Total assets:
Rx Segment	$	134,067	$	121,377
Consumer Health Segment		15,933		16,246
Consolidated assets	$	150,000	$	137,623